Cargando...

Targeting Triple Negative Breast Cancer with a Small-sized Paramagnetic Nanoparticle

There is no available targeted therapy or imaging agent for triple negative breast cancer (TNBC). We developed a small-sized dendrimer-based nanoparticle containing a clinical relevant MRI contrast agent, GdDOTA and a NIR fluorescent dye, DL680. Systemic delivery of dual-modal nanoparticles led to a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Nanomed Nanotechnol
Autores principales: Zhang, Li, Varma, Nadimpalli RS, Gang, Zhang Z., Ewing, James R., Arbab, Ali S, Ali, Meser M
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5180609/
https://ncbi.nlm.nih.gov/pubmed/28018751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2157-7439.1000404
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!